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Abstract We investigated the transmembrane topology of the
P2X2 receptor subunit expressed in HEK 293 cells. Initial studies
using two P2X subunits expressed in tandem indicated that the
amino- and carboxy-termini are on the same side of the
membrane. Immunofluorescence studies showed the cytoplasmic
orientation of the amino- and carboxy-termini. Finally, N-
glycosylation scanning mutagenesis revealed that reporter sites
inserted into the central loop, but not those in the amino- or
carboxy-terminal regions, were glycosylated, thus suggesting an
extracellular placement for that domain. Our results support a
two-transmembrane arrangement for P2X receptors with in-
tracellular amino- and carboxy-termini.
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1. Introduction
P2X receptors are non-selective cation channels activated
by extracellular ATP [1]. These receptors, comprising a family
of seven genes, are thought to be oligomeric in nature. Recent
reports have demonstrated that the individual subunit pro-
teins di¡er in a number of ways, ranging from their agonist
binding pro¢les and biophysical properties [2^7] to their abil-
ity to form heteromeric assemblies [8]. Obviously, investiga-
tion into these varied properties of P2X receptors would be
greatly aided by knowledge of the topography of these pro-
teins.
Current models of P2X protein architecture are based on
computer analysis of their primary sequences, which suggests
that the N-termini are intracellular and that they contain only
two transmembrane (TM) domains [2,3]. This is in marked
contrast to what is known for other ligand-gated ion channels,
such as the nicotinic cholinergic and ionotropic glutamate
receptors which have extracellular N-termini and three or
more transmembrane-spanning segments [9^14]. Although
analyses of primary sequences are commonly used to predict
the topology of membrane proteins [15,16], these protocols
are useful only as a ¢rst step in the elucidation of the two-
dimensional orientation of integral membrane proteins. This
caveat has been amply demonstrated in the case of G-protein
coupled receptors which do not contain consensus signal pep-
tide sequences yet their N-termini are extracellular [17] and
for ionotropic glutamate receptors that were predicted to have
extracellular C-termini which in fact are intracellular [12^14].
Thus, it is extremely important to empirically determine the
topology of these proteins and not to rely on computer anal-
ysis.
In the case of P2X receptors, there is little information
concerning the topological organization of the protein. Muta-
genic studies have shown that two amino acids (aa) located on
the putative extracellular loop of P2X4 are critical for confer-
ring sensitivity to the antagonist PPADS (pyridoxal-phos-
phate-6-azophenyl-2P,4P-disulfonic acid tetrasodium) [5,18].
The only biochemical evidence concerning the topology of
P2X receptors is based on the ¢nding that P2X1 can be gly-
cosylated in vitro [19]. The studies described above are re-
stricted to a few aa located in the central loop and localization
studies have not been reported for any other region of the
protein. The aim of the present report is to provide a struc-
tural model of P2X receptors supported by de¢nitive local-
ization studies. This model is a crucial aid in the design of
experiments investigating not only extracellular areas of the
protein involved in such functions as ligand binding, but also
intracellular domains that can interact with cytosolic proteins
involved in regulatory and/or cellular domain targeting func-
tions. In this study we present data, using a combination of
approaches, that for the ¢rst time demonstrate the topological
organization of P2X receptor subunits.
2. Materials and methods
2.1. DNA constructs
Rat P2X2 cDNA was used as template for ampli¢cation. Muta-
genesis was carried out using the PCR with Vent polymerase (New
England Biolabs). Reaction mixtures were subjected to 32^34 cycles
using the following sequence: 94‡C for 20 s, 55‡C for 30 s, 72‡C for
1^3 min with an additional 7 min at 72‡C to ensure complete exten-
sion. To construct the dimer P2X2/P2X3 cDNA, a stretch of 10 glu-
tamine residues followed by a PstI site was introduced by PCR at the
3P end of P2X2 preceding the stop codon. The rat P2X3 subunit was
used as a template to introduce the NsiI and XhoI sites at the 5P end
adjoining the initiation codon and at the 3P end following the stop
codon respectively. The two PCR fragments were digested with
EcoRI/PstI and NsiI/XhoI respectively, ligated together and subcloned
into pRK-5 [20]. This yielded a construct containing an open reading
frame of 879 aa; aa 1^472 are from P2X2, aa 473^482 are the gluta-
mine spacers, and aa 483^879 are P2X3. For the epitope tagging
experiments, synthetic oligonucleotides were designed to introduce
the FLAG epitope sequence (DYKDDDDK) at the amino-terminus
following the initiation Met (P2X2NF), and at the carboxy-terminus
followed by the stop codon (P2X2CF) of the P2X2 subunit. The three
potential N-linked glycosylation sites N182, N239, and N298 of P2X2
were mutated individually to glutamine (Q) by PCR-mediated over-
lapping extension using the P2X2NF cDNA as a template (these con-
structs were designated P2X2NFvG3). Removal of all three potential
N-linked glycosylation sites was performed in two steps. N-terminally
epitope-tagged P2X2NFvG1 was used as a template to introduce the
second mutation at aa position 239 as described. This PCR product
was then utilized as a template to introduce the third mutation at aa
position 298. This construct, termed P2X2NFvG, was then utilized as
the basis for inserting N-glycosylation consensus sequences NXS/T
into putative hydrophilic regions. Sites were selected in such a way
that in most cases only a single mutation was required to generate the
entire consensus site. Two N-glycosylation sequences were created
simultaneously at the amino-terminal domain by sequentially intro-
ducing the C9N mutation, and the I22N and V24S mutations by
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PCR. Mutations introduced in the central loop were Q206N and
T300N, whereas those selected in the carboxy-terminus were P381N
and A434N. All PCR fragments containing the desired mutations
were digested with EcoRI and XhoI and subcloned into pRK-5 [20].
Mutations were veri¢ed by DNA sequencing with the dideoxynucleo-
tide chain termination method, utilizing the T7 Sequenase kit (Amer-
sham).
2.2. Cell culture and DNA transfection
Human embryonic kidney cells (HEK 293) were grown in Eagle’s
modi¢ed minimal essential medium (MEM) (Gibco BRL) supple-
mented with 10% fetal bovine serum, 50 U/ml penicillin, 50 Wg/ml
streptomycin, and 2 mM glutamine, and placed in a humidi¢ed at-
mosphere containing 5% CO2 at 37‡C. HEK 293 cells grown to 50^
60% con£uence on 35 mm culture dishes were transfected using lip-
ofectamine.
2.3. Electrophysiological recordings
A suspension of transiently transfected cells was made by agitating
the solution bathing the cells attached to the bottom of a single
culture dish using a ¢re-polished Pasteur pipette. Whole cell current
was recorded from single cells using an AxoPatch 200A ampli¢er and
low resistance electrodes (0.5^2 M6). Holding voltage was 340 mV.
Borosilicate recording pipettes were ¢lled with the following intracel-
lular solution (in mM): 140 CsCl, 10 tetraethylammonium-Cl,
5 EGTA, 10 HEPES, pH 7.3 with CsOH. The composition of the
extracellular solution was (in mM): 150 NaCl, 1 CaCl2, 1 MgCl2, 10
glucose, 10 HEPES, pH 7.3 with NaOH. Drugs were applied by
manually moving the electrode and attached cell into the line of
£ow of solutions exiting an array of inlet tubes lying side by side.
Short applications (approximately 3 s) of agonists were accomplished
by moving cells in a linear fashion from control solution through a
drug-containing solution to another control solution.
2.4. Indirect immuno£uorescence and confocal microscopy
Transiently transfected HEK 293 cells grown on glass coverslips
were ¢xed with fresh 2% paraformaldehyde in phosphate-bu¡ered
saline (PBS) for 10 min. In some cases, cells were permeabilized
with 0.05% Nonidet P-40 in PBS for 10 min at room temperature.
Cells were then incubated for 1 h at room temperature in blocking
solution (PBS, 1% bovine serum albumin, 5% goat serum) containing
anti-FLAG M2 monoclonal antibody (mAb) (10 Wg/ml, Kodak).
After several washes with PBS, cells were incubated with diluted £uo-
rescein isothiocyanate (FITC)-conjugated sheep anti-mouse (Sigma).
The cells were then mounted in Vectashield (Vectorlabs) and analyzed
using a MRC 1024 confocal laser scanning microscope (Bio-Rad).
2.5. Western blot analysis
HEK 293 cells grown on 35 mm culture plates were scraped into
100 Wl of sodium dodecyl sulfate (SDS) sample bu¡er. Solubilized
proteins were subjected to 12% SDS-polyacrylamide gel electrophore-
sis (SDS-PAGE), followed by transfer to Hybond (Amersham). The
blots were incubated with 10 Wg/ml of the FLAG-speci¢c mAb M2
(Kodak) followed by peroxidase-conjugated sheep anti-mouse anti-
body (Amersham). Immunoreactivity was visualized by enhanced
chemiluminescence using an ECL kit (Amersham) according to the
manufacturer’s instruction. For treatment with endoglycosidase H,
solubilized proteins from transfected cells were incubated with 2 mU
of endoglycosidase H (Boehringer Mannheim) at 30‡C for 18 h. Sam-
ples were then analyzed by SDS-PAGE as described.
3. Results and discussion
The elucidation of the topography of the P2X subunit pro-
tein in the cell membrane is an important and necessary step
toward identifying the structure of the ATP binding site, the
domains involved in the formation of the channel pore, sub-
unit assembly and the possible regulatory sites of the protein.
As a ¢rst step in this process, we utilized a functional ap-
proach to investigate whether the amino- and carboxy-termini
were localized to the same side of the membrane. To do so, we
took advantage of the ability of these proteins to form homo-
and hetero-oligomeric receptor assemblies. We hypothesized
that if the amino- and carboxy-termini of a single P2X sub-
unit are both on the same side of the membrane, two subunits
placed in tandem as a single polypeptide would each be ex-
cepted to fold properly and be able to participate in the for-
mation of functional receptor assemblies. If the two termini
are not on the same side of the membrane, then the second
subunit of the tandem would not fold properly because of the
constraints placed on it by being covalently attached to the
¢rst subunit. Tandem channels have been employed success-
fully in a variety of contexts that include determination of
membrane topology [21], subunit stoichiometry [22,23] and
subunit positional e¡ects [24]. Whether or not subunits on
the same tandem both contribute to the same receptor assem-
bly is not pertinent; what is important is the phenotype of the
observed proteins. Previous studies have shown that the P2X2
and P2X3 subunits can co-assemble to form heteromeric chan-
nels that exhibit unique properties di¡ering from either parent
expressed as homomeric receptors. Homomeric P2X3 recep-
tors show strong desensitization in response to ATP and K,L-
methylene-ATP (KLme-ATP), homomeric P2X2 receptors are
insensitive to KLme-ATP and show much less desensitization
of ATP currents, whereas co-expression of the two results in a
heteromeric channel with a non-desensitizing KLme-ATP cur-
rent ([8] and Fig. 1). We therefore engineered a tandem cDNA
which resulted in a chimeric protein containing a P2X2 sub-
unit linked to a P2X3 subunit (designated P2X2:3). We chose
P2X3 as the second subunit in the tandem to ensure that
functional channels containing it would be sensitive to
KLme-ATP. In this scenario, if only the ¢rst subunit in the
tandem was folded properly and was functional, then any
resulting receptors would have the homomeric P2X2 pheno-
type and be insensitive to KLme-ATP (Fig. 1A). However, if
the second subunit in the tandem was also folded properly,
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Fig. 1. KLme-ATP response in HEK 293 cells transfected with ho-
momeric, heteromeric, and engineered tandem P2X subunits. Homo-
meric P2X2 subunits are insensitive to the e¡ect of KLme-ATP (A),
whereas homomeric P2X3 subunits show a strong desensitization in
response to KLme-ATP (B). Co-expression of P2X2 and P2X3 sub-
units yields a receptor with a non-desensitizing KLme-ATP response
(C). The P2X2:3 tandem construct also gives a non-desensitizing
KLme-ATP response (D) suggesting that both subunits are folded
properly. Note: Cells transfected with wild-type P2X2 gave a robust
ATP response, con¢rming the presence of functional receptors (not
shown).
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then KLme-ATP-responsive receptors should be detected that
exhibited a phenotype resembling either that of P2X3 alone
(Fig. 1B) or that of the heteromeric P2X2/P2X3 receptor (Fig.
1C). Demonstration of KLme-ATP sensitivity would therefore
indicate that the second (P2X3) subunit’s N-terminus was on
the same side of the membrane as the C-terminus of the ¢rst
subunit (P2X2). As shown in Fig. 1D, the P2X2:3 tandem
construct did indeed give a functional channel that exhibited
a non-desensitizing current in response to KLme-ATP, and the
time course of this response was similar to that observed with
the heteromeric receptor formed by P2X2 and P2X3 subunits
(Fig. 1). Such a ¢nding can only be explained by the correct
folding of both subunits present in the tandem. Thus, these
results demonstrate that in functional P2X subunits the ami-
no- and carboxy-termini must be located on the same side of
the membrane.
We next used immuno£uorescence combined with confocal
microscopy to determine if the termini are intracellular or
extracellular. To accomplish this, we ¢rst epitope-tagged the
P2X2 subunit by engineering the FLAG epitope into either
the N-terminus (P2X2NF) or C-terminus (P2X2CF). The ex-
pression of homomeric P2X2NF or P2X2CF resulted in an
ATP response resembling that of the wild-type P2X2 (Fig.
2), indicating that these epitope-tagged subunits are capable
of forming functional receptors. No detectable immuno£uo-
rescence was observed in untransfected HEK 293 cells or cells
transfected with wild-type (untagged) P2X2 subunits (data not
shown). In the case of P2X2NF or P2X2CF, the mAb M2 did
not detect either of the tagged P2X2 receptors at the mem-
branes of non-permeabilized cells (Fig. 3A,C) but did in per-
meabilized cells (Fig. 3B,D), indicating that both the amino-
and the carboxy-termini are intracellular in orientation. These
¢ndings are in line with other results from our laboratories
that demonstrate the N-terminal portion of TM2 faces the
extracellular space and that the C-terminal portion of TM2
resides intracellularly [25].
To investigate the membrane sideness of the entire protein,
we utilized the fact that N-glycosylation of proteins occurs
only on domains that are destined to be extracellular. Such
an approach has been used successfully for topographic anal-
ysis of other channel proteins [13,14,26,27]. Analysis of the
P2X2 primary sequence indicates three potential N-linked gly-
cosylation sites at aa positions 182, 239, and 299. To deter-
mine which, if any, of these sites are glycosylated, we removed
each site individually from P2X2NF. Western blot analysis of
cells expressing the wild-type and glycosylation mutant
P2X2NF subunits was then carried out using the anti-
FLAG mAb M2. No bands were detected when the cells
were transfected with the wild-type untagged P2X2 (Fig. 4,
lane 1). However, cells transfected with P2X2NF produced
an N-glycosylated protein of approximately 70 kDa (Fig. 4,
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Fig. 3. Detection of epitope-tagged P2X2 subunits by indirect immuno£uorescence and confocal microscopy. HEK 293 cells expressing P2X2NF
(A,B) or P2X2CF (C,D) were stained with M2 mAb under non-permeabilizing (left panels) and permeabilizing conditions (right panels). Cells
were then incubated with £uorescein anti-mouse and subjected to immuno£uorescence analysis using a Bio-Rad confocal microscope. The ami-
no- and carboxy-termini of the tagged P2X2 subunits were labeled only after permeabilization of the plasma membrane.
Fig. 2. ATP responses of wild-type and epitope-tagged P2X2 recep-
tor subunits. Recordings were obtained 24^48 h after HEK 293 cells
were transfected with 1 Wg of cDNA. The currents were elicited by
10 WM ATP from a holding potential of 340 mV. Traces are repre-
sentative of at least three separate experiments.
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lane 2), as treatment with endoglycosidase H reduced the size
of the protein to approximately 55 kDa (Fig. 4, lane 3). Re-
moval of each of the three potential N-glycosylation sites did
not alter ATP-induced currents in these receptors (data not
shown), but did lead to an increase in the mobility of the
mutant proteins as compared with P2X2NF (Fig. 4, lanes 4,
5, and 6). Moreover, when all three sites were removed from
P2X2 (designated P2X2NFvG), the protein was of a similar
size to the endoglycosidase H-treated P2X2NF (Fig. 4, lane 7).
These results indicate that each N-linked glycosylation site of
P2X2 is used in vivo and demonstrate that these residues are
extracellular on functional proteins.
To con¢rm the intracellular orientation of the N- and C-
termini, we used an N-glycosylation-linked scanning protocol
in which we engineered N-glycosylation consensus sequences
into putative intracellular and extracellular regions of
P2X2NF and examined their accessibility to the glycosylation
machinery. We used P2X2NFvG as the parent construct so
that N-glycosylation could only occur at the engineered sites,
and we increased the chances of detecting glycosylation by
inserting two consensus sequences. These sites were placed
into one of three domains: the amino-terminus (preceding
TM1, and designated P2X2NFvG-N), the central loop (des-
ignated P2X2NFvG-L), or the carboxy-terminal domain (fol-
lowing TM2, and designated P2X2NFvG-C). Fig. 5 shows the
gel mobility shift analysis for the various scanning mutants. A
decreased mobility was observed for P2X2NFvG-L compared
to that of P2X2NFvG (Fig. 5, lanes 2 and 4), indicating that
the insertion of consensus sites at positions 206 and 300 in the
central loop yielded a glycosylated receptor, and therefore
further demonstrates the extracellular localization of this re-
gion. On the other hand, no glycosylation was observed when
sites were inserted at positions 9 and 22 in the amino-terminus
(Fig. 5, lane 3). Similar results were obtained when sites were
inserted at positions 381 and 434 in the carboxy-terminus
(Fig. 5, lane 5). These observations suggest that these sites
were not available for glycosylation and therefore are intra-
cellular.
In summary, the three independent sets of experiments pre-
sented in this report provide the ¢rst experimental evaluation
of the topological model of P2X receptors deduced from hy-
dropathy plots. Individually these strategies each have certain,
but non-overlapping, limitations. For instance, insertion of
epitopes or glycosylation consensus sequences might alter
the secondary/tertiary properties of the protein and thus con-
found the interpretation of the results. Hence, the most com-
pelling outcome of these various approaches would be that
supported by convergent results. Indeed, such a conclusion
was obtained in this study. The data are consistent with a
two-transmembrane domain arrangement for P2X receptors
with intracellular amino- and carboxy-termini and a large ex-
tracellular loop containing 10 positionally conserved cysteine
residues. Although P2X receptors have no obvious primary
sequence homology with other ligand-gated ion channels, the
structural features described in this report are shared by an
entirely di¡erent class of ion channels that include the ami-
loride-sensitive epithelial sodium channel [28], the FMRF-
gated channel [29], and the mechanosensitive channel of Cae-
norhabditis elegans [30]. Our ¢ndings provide a starting point
for the rational design of experiments aimed at elucidating the
structural elements of P2X receptors that are involved in
channel function and, by extension, in ATP-mediated intra-
cellular signalling.
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